Articles Referencing HALO

Mid-Afternoon Market Update: Optimer Falls as Halozyme Rockets Upwards

5/16/2013, 3:35 pm from Benzinga in Investing, Commodities, Economy, International

Toward the end of trading Thursday, the Dow was down 0.10 percent to 15,259.91, while the NASDAQ rose 0.13 percent to 3,476.15. The S&P traded down, falling 0.23 percent to 1,654.47. ... Read >>

Mid-Day Market Update: US Stocks Fluctuate, Cisco Systems Up on Better-than-Expected Earnings

5/16/2013, 1:38 pm from Benzinga in Investing, Commodities, Economy, International

Midway through trading Thursday, the Dow was up 0.05 percent to 15,282.91, while the NASDAQ rose 0.05 percent to 3,477.15. The S&P traded down, falling 0.08 percent to 1,657.47. Top... Read >>

ViroPharma Reports Loss in 1Q - Analyst Blog

5/2/2013, 1:53 pm from Zacks.com in Investing, Business, Stocks

ViroPharma Inc.'s  ( VPHM ) first quarter 2013 adjusted loss (excluding special items but including stock-based compensation) came in at 7 cents per share compared to year-ago earnings... Read >>

Market Wrap for Friday, March 22: Stocks Rise on Hopes of Bailout Deal for Cyprus

3/22/2013, 4:17 pm from Benzinga in Investing, Bonds, Commodities, Futures, International

The U.S. stock market closed out a choppy week with a gain as policymakers in Cyprus were in talks with EU officials to secure a bailout for the Mediterranean island which is facing a... Read >>

Mid-Day Market Update: Micron Surges On Upbeat Revenue, Informatica Declines

3/22/2013, 1:23 pm from Benzinga in Investing, Commodities, Economy, International

Midway through trading Friday, the Dow traded up 0.52 percent to 14,495.91 while the NASDAQ gained 0.45 percent to 3,237.05. The S&P also rose, gaining 0.55 percent to 1,554.33. Index... Read >>

ViroPharma Tops on All Fronts - Analyst Blog

2/28/2013, 4:38 pm from Zacks.com in Investing, Business, Stocks

ViroPharma Inc.'s ( VPHM ) fourth quarter 2012 adjusted earnings (including stock-based compensation) of 3 cents per share were above the Zacks Consensus Estimate of a penny but... Read >>

One Biotech Stock Investors are Unfairly Ignoring

1/15/2013, 9:00 am from Benzinga in Investing, Investing Ideas

Shares of biotech company Halozyme Therapeutics (NASDAQ: HALO ) were unchanged in pre-market trading on Tuesday following Monday's gain of more than 15 percent. Investors bid up the stock... Read >>

Upbeat 2013 from ViroPharma - Analyst Blog

1/8/2013, 5:29 pm from Zacks.com in Investing, Business, Stocks

ViroPharma Incorporated ( VPHM ) recently provided guidance for 2013. ViroPharma expects net product sales between $450 million and $475 million in 2013 on a worldwide basis.... Read >>

Pfizer Signs a Couple of Deals - Analyst Blog

12/26/2012, 3:50 pm from Zacks.com in Investing, Business, Stocks

Pfizer ( PFE ) recently entered into two deals. While one deal was signed with biopharma company Halozyme Therapeutics, Inc. ( HALO ), the second deal was signed with clinical... Read >>

Mid-Afternoon Update: Herbalife Takes a Bigger Beating, Markets Still Red

12/21/2012, 3:54 pm from Benzinga in Investing, Commodities, Earnings, Economy, International

Toward the end of trading Friday, the Dow traded down 0.90 percent to 13,191.24 while the NASDAQ fell 1.02 percent to 3,019.21. The S&P also fell, decreasing 0.85 percent to 1,431.42. ... Read >>

Pre-Market Most Active for Dec 21, 2012 : BAC, RIMM, ITUB, QQQ, NOK, TOT, SIRI, C, FB, NJ, HALO, ASCA

12/21/2012, 8:40 am from NASDAQ.com News in News Headlines, Pre-market Most Active

The NASDAQ 100 Pre-Market Indicator is down -28.92 to 2,664.63. The total Pre-Market volume is currently 7,875,926 shares traded. The following are the most active stocks for the... Read >>

After Hours Most Active for Aug 1, 2012 : SAN, GMCR, NOK, FSLR, BBVA, SBUX, BAC, JNJ, LEN, HALO, QQQ, SPLS

8/1/2012, 4:44 pm from NASDAQ.com News in News Headlines, After Hours Most Active

The NASDAQ 100 After Hours Indicator is down -3.05 to 2,632.08. The total After hours volume is currently 15,550,183 shares traded. The following are the most active stocks for the after... Read >>

I've Found at Least 2 Bargain Stocks Amidst April's Biggest Losers

5/3/2012, 8:30 am from David Sterman in Investing, Investing Ideas

The rising market during the past several months has helped boost virtually every portfolio. Yet without the wind at your back, marking steady gains becomes that much more challenging.... Read >>

Get These 3 Stocks for Less than What Insiders Paid

4/27/2012, 11:30 am from David Sterman in Investing, Investing Ideas

When executives of a company step in and buy its stock, it can provide a glimpse into an overlooked or misunderstood value opportunity. Sadly, these insiders are often lousy market... Read >>

A Legendary Biotech Investor Just Spent $14 Million on this Stock

4/17/2012, 11:30 am from David Sterman in Investing, Investing Ideas

Randal J. Kirk is beside himself right now. The legendary biotech investor, who is now worth more than $2 billion, made a rare misstep by plunking down $14 million (at $10.61 a share) on ... Read >>